Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ocular Therapeutix, Inc.(OCUL) | 1,310,000 | 2,635,287 | +1,325,287 | $5.84M | $23.98M | 15.58% | +$18.14M |
| Praxis Precision Medicines, Inc.(PRAX) | 299,636 | 162,302 | -137,334 | $6.68M | $9.90M | 6.43% | +$3.23M |
| Mersana Therapeutics Inc | 2,368,000 | 2,164,628 | -203,372 | $5.49M | $9.70M | 6.30% | +$4.20M |
| Taysha Gene Therapies, Inc.(TSHA) | 3,589,333 | 3,333,333 | -256,000 | $6.35M | $9.57M | 6.21% | +$3.21M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 366,015 | 326,787 | -39,228 | $10.97M | $8.80M | 5.72% | -$2.17M |
| Sarepta Therapeutics, Inc.(SRPT) | 70,600 | 64,162 | -6,438 | $6.81M | $8.31M | 5.40% | +$1.50M |
| Vaxcyte, Inc.(PCVX) | 117,373 | 104,830 | -12,543 | $7.37M | $7.16M | 4.65% | -$210.1K |
| Enliven Therapeutics Inc | 123,876 | 396,099 | +272,223 | $1.71M | $6.97M | 4.53% | +$5.25M |
| Tourmaline Bio Inc | 231,882 | 261,108 | +29,226 | $6.07M | $5.98M | 3.88% | -$91.3K |
| Applied Therapeutics Inc | 525,100 | 792,000 | +266,900 | $1.76M | $5.39M | 3.50% | +$3.63M |
| Dyne Therapeutics, Inc.(DYN) | 147,836 | 184,500 | +36,664 | $1.97M | $5.24M | 3.40% | +$3.27M |
| Disc Medicine, Inc.(IRON) | 115,500 | 76,800 | -38,700 | $6.67M | $4.78M | 3.11% | -$1.89M |
| Revolution Medicines, Inc.(RVMD) | 160,000 | 143,777 | -16,223 | $4.59M | $4.63M | 3.01% | +$45.1K |
| Celldex Therapeutics, Inc.(CLDX) | 69,400 | 109,000 | +39,600 | $2.75M | $4.57M | 2.97% | +$1.82M |
| Whitehawk Therapeutics, Inc.(WHWK) | 1,849,402 | 1,849,402 | 0 | $3.74M | $4.33M | 2.81% | +$591.8K |
| Hillevax Inc | 324,600 | 250,609 | -73,991 | $5.21M | $4.17M | 2.71% | -$1.04M |
| Crinetics Pharmaceuticals | 87,500 | 78,403 | -9,097 | $3.11M | $3.67M | 2.38% | +$556.8K |
| Viridian Therapeutics, Inc.(VRDN) | 281,500 | 199,433 | -82,067 | $6.13M | $3.49M | 2.27% | -$2.64M |
| Terns Pharmaceuticals Inc | 555,260 | 465,079 | -90,181 | $3.60M | $3.05M | 1.98% | -$552.7K |
| Immunovant, Inc.(IMVT) | 119,489 | 92,346 | -27,143 | $5.03M | $2.98M | 1.94% | -$2.05M |
| Verastem, Inc.(VSTM) | 232,249 | 207,095 | -25,154 | $1.89M | $2.44M | 1.59% | +$553.2K |
| Arcellx Inc COMMON STOCK | 77,000 | 34,500 | -42,500 | $4.27M | $2.40M | 1.56% | -$1.87M |
| Kura Oncology, Inc.(KURA) | 701,349 | 90,000 | -611,349 | $10.09M | $1.92M | 1.25% | -$8.17M |
| Insmed Incorporated(INSM) | 29,500 | 61,718 | +32,218 | $914.2K | $1.67M | 1.09% | +$760.2K |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 55,262 | +55,262 | $0 | $1.62M | 1.05% | +$1.62M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 103,992 | +103,992 | $0 | $1.43M | 0.93% | +$1.43M |
| Mereo BioPharma Group plcADS(MREO) | 0 | 397,884 | +397,884 | $0 | $1.31M | 0.85% | +$1.31M |
| Lyra Therapeutics Inc | 0 | 173,320 | +173,320 | $0 | $1.08M | 0.70% | +$1.08M |
| Cypherpunk Technologies Inc.(CYPH) | 354,166 | 354,166 | 0 | $1.47M | $942.1K | 0.61% | -$525.9K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 20,000 | +20,000 | $0 | $933.8K | 0.61% | +$933.8K |
| Intra-Cellular Therapies Inc. | 0 | 13,300 | +13,300 | $0 | $920.4K | 0.60% | +$920.4K |
| Cellectar Biosciences, Inc.(CLRB) | 477,500 | 143,500 | -334,000 | $1.32M | $571.1K | 0.37% | -$751.5K |
| Nuvation Bio Inc.W EXP 07 07 2027(NUVB) | 90,832 | 90,832 | 0 | $5.5K | $27.5K | 0.02% | +$22.0K |
| An2 Therapeutics Inc | 132,000 | 0 | -132,000 | $2.70M | $0 | — | -$2.70M |
| Apellis Pharmaceuticals Inc COM | 76,100 | 0 | -76,100 | $4.56M | $0 | — | -$4.56M |
| argenx SEADR(ARGX) | 2,400 | 0 | -2,400 | $913.0K | $0 | — | -$913.0K |
| Centessa Pharmaceuticals PlcADS | 38,138 | 0 | -38,138 | $303.6K | $0 | — | -$303.6K |
| Cymabay Therapeutics Inc | 492,155 | 0 | -492,155 | $11.62M | $0 | — | -$11.62M |
| EyePoint, Inc.(EYPT) | 425,128 | 0 | -425,128 | $9.82M | $0 | — | -$9.82M |
| 4d Molecular Therapeutics Inc | 74,500 | 0 | -74,500 | $1.51M | $0 | — | -$1.51M |
| Rayzebio Inc | 378,069 | 0 | -378,069 | $23.50M | $0 | — | -$23.50M |
| Springworks Therapeutics Inc | 10,000 | 0 | -10,000 | $365.0K | $0 | — | -$365.0K |
| Tyra Biosciences, Inc.(TYRA) | 8,867 | 0 | -8,867 | $122.8K | $0 | — | -$122.8K |
| Verona Pharma PlcADS | 19,000 | 0 | -19,000 | $377.7K | $0 | — | -$377.7K |